I-EPPS Cas: 16052-06-5 I-crystalline powder emhlophe 99% 4-(2-Hydroxyethyl)pi
Inombolo Yekhathalogi | XD90114 |
Igama Lomkhiqizo | EPPS |
I-CAS | 16052-06-5 |
I-Molecular Formula | I-C9H20N2O4S |
Isisindo samangqamuzana | 252.33 |
Imininingwane Yesitoreji | I-ambient |
Ikhodi Yentela Evumelanisiwe | 29335995 |
Ukucaciswa Komkhiqizo
pH | 5 - 6.5 |
Ukulahlekelwa Ekumisweni | <1% |
Isivivinyo | >99% |
Ukubukeka | I-crystalline powder emhlophe |
I-Solubility 0.1M amanzi | Isixazululo esicacile, esingenambala |
Umphumela we-acidosis, uphawu lwamakhemikhali ezinto eziphilayo ze-tumor microenvironment, ekuqhubekeleni phambili komdlavuza kanye ne-metastasis iyinkimbinkimbi.Kokubili imiphumela ekhuthazayo kanye ne-anti-tumorigenic ye-acidosis ibikiwe futhi imvelo ene-asidi iye yaxhashazwa ukulethwa kwezidakamizwa ezithile, ama-imaging agents, kanye nezakhi zofuzo ezakhiwe zibe izimila.Kulolu cwaningo siphenya ukusabalala nokunamathela okugxile kwamaseli e-melanoma e-B16F10 enziwe ngofuzo ukuze aveze ngokwedlulele i-pH-sensing G protein-coupled receptor GPR4.Ngokusebenzisa izivivinyo zokunamathiselwe kwiseli sithole ukuthi i-GPR4 overexpression ilibazise ukusakazeka kweseli futhi yashintsha ukwenziwa kwasendaweni kwendawo ye-dynamic focal adhesion complex, njengokwenziwa kwasendaweni kwe-phosphorylated focal adhesion kinase (FAK) kanye ne-paxillin, ku-acidic pH.Amaphrotheni e-G angaba khona kanye nezindlela zokusayina ezansi nomfula ezinesibopho sale miphumela nazo zaphenywa.Ngokusebenzisa i-Rho inhibitor CT04 (C3 transferase), i-Rho-associated kinase (ROCK) inhibitors Y27632 kanye ne-thiazovivin, i-myosin light chain kinase (MLCK) inhibitor staurosporine noma i-G12/13 inhibitory construct, ukusabalalisa kwamaseli kwabuyiselwa lapho ukwenziwa kusebenze kwezindlela ze-Gq ne-Gs kube nomthelela omncane noma kwangenawo nhlobo.Sekukonke imiphumela yethu ikhombisa ukuthi ngokusebenzisa indlela ye-G12/13/Rho yokusayina i-GPR4 imodela amandla okunamathela okugxilile futhi inciphise ukusabalala kwamaseli kanye nokugoqeka kwe-membrane.